-+ 0.00%
-+ 0.00%
-+ 0.00%
Alligator Bioscience names CFO Johan Giléus CEO effective Jan. 1, 2027
Share
Listen to the news
Alligator Bioscience names CFO Johan Giléus CEO effective Jan. 1, 2027
  • Alligator Bioscience named CFO Johan Giléus as CEO, effective Jan. 1, 2027.
  • Outgoing CEO Søren Bregenholt will step down at year-end 2026.
  • Giléus will hold both CEO and CFO roles as the company narrows focus to its financial interest in HLX22.
  • Giléus joined Alligator as CFO in August 2024, following a career at Deloitte Sweden focused on M&A and financial reporting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alligator Bioscience AB published the original content used to generate this news brief on October 04, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending